The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · IEX Real-Time Price · USD
1.216
-0.014 (-1.14%)
Apr 19, 2024, 10:33 AM EDT - Market open
The Oncology Institute Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for TOI stock have an average target of 2.25, with a low estimate of 2.00 and a high estimate of 2.50. The average target predicts an increase of 85.03% from the current stock price of 1.22.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 26, 2024.
Analyst Ratings
The average analyst rating for TOI stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $2.5 | Strong Buy | Initiates | $2.5 | +105.59% | Feb 26, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | +64.47% | Jun 16, 2023 |
| Guggenheim | Guggenheim | Hold Maintains $6 → $3 | Hold | Maintains | $6 → $3 | +146.71% | Mar 20, 2023 |
| Guggenheim | Guggenheim | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +393.42% | Nov 11, 2022 |
| Jefferies | Jefferies | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +722.37% | Aug 15, 2022 |
Financial Forecast
Revenue This Year
416.63M
from 324.24M
Increased by 28.49%
Revenue Next Year
487.63M
from 416.63M
Increased by 17.04%
EPS This Year
-0.36
from -0.92
EPS Next Year
-0.17
from -0.36
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 433.1M | 506.9M |
| Avg | 416.6M | 487.6M |
| Low | 404.3M | 473.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 33.6% | 21.7% |
| Avg | 28.5% | 17.0% |
| Low | 24.7% | 13.6% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -0.38 | -0.18 |
| Avg | -0.36 | -0.17 |
| Low | -0.35 | -0.17 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.